Folic acid

Very little on a supplement label is backed by an intervention trial. Folic acid is the exception, and the regulation that authorises its claim is unusually candid about both the strength of the evidence and its edges.

What the claim rests on

The US health claim regulation names its source. The strongest evidence came from a Medical Research Council trial in the United Kingdom, in women at risk of recurrence, who took 4 milligrams of folic acid daily before conception and into early pregnancy and had a reduced risk of a child with a neural tube defect.

The regulation then does something careful. It notes that products at that 4 milligram level are drugs, not supplements, and works down to what the general population evidence supports: the Public Health Service “has inferred that folate alone at levels of 400 mcg (0.4 mg) per day may reduce the risk of neural tube defects”.

Four hundred micrograms. That is the number on the front of every prenatal supplement, and it traces to a specific inference recorded in a specific regulation rather than to consensus in the air.

The regulation is equally clear about why timing matters more than duration: “Because the neural tube forms and closes during early pregnancy, the defect may occur before a woman realizes that she is pregnant.” This is the rare nutrient where starting when you find out is starting late.

The ceiling inside the claim

Here is the part almost nothing else on a label does.

For foods carrying more than the daily value of folate, the model claim FDA supplies reads: “Women who consume healthful diets with adequate folate may reduce their risk of having a child with birth defects of the brain or spinal cord. Folate intake should not exceed 250% of the DV (1,000 mcg).”

A health claim that contains its own upper limit. The reason is not toxicity in the ordinary sense. The NHS states it directly: doses “higher than 1mg can mask the symptoms of vitamin B12 deficiency, which can eventually damage the nervous system if it’s not spotted and treated”, and it notes this is particularly a concern for older people.

Folic acid corrects the anaemia that Cyanocobalamin deficiency causes without correcting the nerve damage that runs alongside it. The blood test comes back normal and the neurological injury continues. That is the interaction the ceiling exists for, and it is the clearest example on this site of two nutrients whose labels should be read together.

Folate against folic acid

They are not quite the same thing and the words are used loosely.

Folate is the family, including the forms occurring naturally in leafy vegetables, legumes and liver. Folic acid is the manufactured form, more stable and better absorbed, and it is what fortification and supplementation use. The regulation itself treats the words as interchangeable, defining folic acid as “also known as folacin or folate”.

Methylfolate is sold as the superior option on the argument that it skips a conversion step some people perform less efficiently. That conversion difference is real. Whether it changes outcomes at ordinary doses is a much weaker claim than the marketing implies, and the entire body of neural tube evidence, including the trial the regulation names, was built on folic acid.

Where it turns up without being asked for

Fortification is the reason the total is easy to lose track of. The regulation permits folic acid in breakfast cereals at up to 400 micrograms per serving, which is a full daily value in one bowl, and many countries fortify flour so that bread and pasta carry it too.

That is deliberate public health policy and it works. It also means a person taking a supplement is adding to a base they did not choose, which is exactly the arithmetic the ceiling in the claim is asking you to do.